Announcements
June 28, 2012 -- EPA has developed the Endocrine Disruptor Screening Program Comprehensive Management Plan providing strategic guidance to agency personnel and outlining the program's critical activities over the next five years.
June 5, 2012 - TSCA Section 4 and related 12(b) Sunset Table updated.
May 24, 2012 -- EPA will hold a public meeting on Wednesday, June 27, 2012 to negotiate an Enforceable Consent Agreement (ECA) to collect data on high production volume chemicals D4 and D5 siloxanes. Interested parties must notify the Agency prior to the meeting in order to participate. Learn more.
May 22, 2012 -- EPA hosted a Webinar on the CDX registration process and use of the TSCA Section 8(d) electronic reporting tool. See the Webinar screen shots and audio file.
May 14, 2012 -- EPA partially withdrew a direct final rule issued last March revoking certain test requirements for 10 chemicals. Because EPA received an adverse comment regarding one of the 10 chemicals, C.I. Pigment Blue 61, it has withdrawn and is re-proposing the revocation for C.I. Pigment Blue 61. The comment period for the proposed rule will be open until June 13, 2012. This action does not affect the revocation of test requirements for the other nine chemicals that were subject to the direct final rule issued last March.
EPA has broad authority under the law to issue:
- Information collection regulations that require the submission of health and safety studies which are known or available to those who manufacture, process, or distribute in commerce specified chemicals; and
- Regulations designed to gather information from manufacturers and processors about production/import volumes, chemical uses and methods of disposal, and the extent to which people and the environment are exposed.
ABOUT CHEMICAL TESTING DATA DEVELOPMENT (TESTING)
- Test Rules
- Testing Policy
- Program Objectives
- Master Testing List
- Chemical Right-To-Know
- Interagency Testing Committee
- OECD/SIDS
- International Chemical Safety
- Information Gathering Authority Section 8(a)
- Allegations of Significant Adverse Reactions Section 8(c)
- Unpublished Health and Safety Studies Section 8(d)
- Substantial Risk Information Section 8(e)
- TSCA Export Notification Section 12(b)
- TSCA Import CertificationSection 13
- Testing Results Overview
- Individual Testing Results
- Testing Results by CAS No. (PDF, 174pp, 827KB, About PDF)
- Testing Results by Chemical Name (PDF, 172pp, 828KB, About PDF)
- Section 4
- Section 5
- Section 8
- Section 12
- Section 21
- Import/Export Policies
- TSCA Section 13 Custom Import Regulations 19 CFR sections 12.118 through 12.127 and 127.28 amended)
- Product Stewardship/Memoradum of Understanding